INIS
modulation
100%
children
100%
blood pressure
100%
diseases
80%
sensitivity
60%
patients
40%
therapy
40%
control
40%
comparative evaluations
40%
range
40%
data
20%
regulations
20%
correlations
20%
assessments
20%
death
20%
muscles
20%
genotype
20%
environment
20%
dna sequencing
20%
hafnium-alpha
20%
Keyphrases
Duchenne muscular Dystrophy
100%
Autonomic Modulation
100%
Cardio
100%
Heart Rate Variability
33%
Baroreceptor Function
33%
Blood Pressure Variability
33%
Age of Onset
22%
Duration of Illness
22%
Cardioprotective Therapy
22%
Genotype
11%
Healthy Controls
11%
Age-matched
11%
Cardiac Dysfunction
11%
DNA Sequencing
11%
Heart Rate
11%
Clinical State
11%
Early Diagnosis
11%
Disease Progression
11%
Disease Severity
11%
Muscle Disease
11%
Systolic Blood Pressure
11%
Autonomic Regulation
11%
Duplication
11%
X-linked
11%
Cardiac Autonomic Function
11%
Cardiopulmonary Function
11%
Coefficient of Variance
11%
Parameter Sensitivity
11%
Variability Parameters
11%
Autonomic Abnormalities
11%
Non-invasive Method
11%
Beat-to-beat Blood Pressure
11%
Am(III)
11%
Biochemistry, Genetics and Molecular Biology
Heart Rate Variability
100%
Blood Pressure Variability
100%
Baroreceptor
100%
Genotyping
33%
Blood Pressure
33%
Systolic Blood Pressure
33%
Prospective Study
33%
DNA Sequence
33%
Cardiopulmonary Hemodynamics
33%
Immunology and Microbiology
Heart Rate Variability
100%
Blood Pressure Variability
100%
Blood Pressure
33%
Systolic Blood Pressure
33%
Cardiopulmonary Hemodynamics
33%
DNA Sequence
33%
Medicine and Dentistry
Duchenne Muscular Dystrophy
100%
Disease
33%
Heart Rate Variability
33%
Blood Pressure Variability
33%
Prospective Study
11%
Blood Pressure
11%
Disease Severity
11%
Muscle Disease
11%
Disease Exacerbation
11%
Systolic Blood Pressure
11%
Early Diagnosis
11%
Non Invasive Procedure
11%
Cardiopulmonary Hemodynamics
11%
Onset Age
11%
DNA Sequence
11%
Neuroscience
Muscular Dystrophy
100%
Heart Rate Variability
33%
Baroreceptor
33%
DNA Sequencing
11%
Muscle Disorder
11%
Autonomic Regulation
11%
Electrocardiography
11%
Pharmacology, Toxicology and Pharmaceutical Science
Duchenne Muscular Dystrophy
100%
Disease
33%
Prospective Study
11%
Disease Exacerbation
11%
Disease Severity
11%
Muscle Disease
11%
Onset Age
11%